Delivery Order SPE2DB20D7059-SPE2DB25FQDX5

Award Date 4/10/25
Potential Completion Date 5/1/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Revlimid 10 mg capsules. The contract has a ceiling value of $49,926.80 and a performance period ending on May 23, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Revlimid 10 mg capsules, a prescription medication. The contract has a ceiling value of $68,649.37 and is a firm fixed-price delivery order, with a performance period ending on May 8, 2025. The contract is not set-aside and was openly competed. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $56,490.52 firm-fixed-price contract is for the delivery of Revlimid 10 mg capsules and has an ultimate completion date of January 22, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Revlimid 10 mg capsules. The contract has a firm fixed price of $178,310.12 and a period of performance through August 8, 2024. The award is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for delivering a wide range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Revlimid 15 mg capsules. The contract has a ceiling value of $18,722.57 and a period of performance through May 23, 2025. It is a firm fixed-price contract, without any set-aside designation. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $199,707.28, is a delivery order for the supply of REVLIMID 10 MG CAPSULE 28S, a prescription medication. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 10 mg capsules of the drug Revlimid, valued at $49,926.80. The order has a firm fixed price and an ultimate completion date of August 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which enables the agency to efficiently procure a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $49,926.80. The order is for REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of October 9, 2024 and is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REVLIMID 10 MG CAPSULE 28S, a prescription medication, with a ceiling value of $74,890.20 and a performance period through June 3, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REVLIMID 20 MG CAPSULE 100S. The award, valued at $89,155.06, has an ultimate completion date of October 8, 2024. AmerisourceBergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a comprehensive range of medical commodities. This...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQDX5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $49,926.80, is for the delivery of the prescription medication Revlimid 10 mg capsules. It is a firm-fixed price, non-set-aside contract with a performance period through May 1, 2025.

AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 5:55 PM